1-(tert-Butyloxycarbonyl)-3-Fluoro-4-aminopiperidine

Chemical available in other sizes

Please inquire size and price
Stock availability

Available in 2-3 weeks
Cas number

934536-10-4
Chemical s molecular weight

218.27
Chemical s main applications

1-(tert-Butyloxycarbonyl)-3-Fluoro-4-aminopiperidine is a reactant in the preparation of pharmaceutical compounds which are antagonists of CGRP (Calcitonin gene-related peptide) receptors and useful in the treatment of migraine.
Other name

tert-Butyl 4-Amino-3-fluoropiperidine-1-carboxylate; 4-Amino-3-fluoro-1,1-dimethylethylester-1-piperidinecarboxylic Acid;
Chemical s formula

C10H19FN2O2
Physical properties

No Data Available
Melting temperature

No Data Available
Boiling temperature

No Data Available
Chemical s soluble in

No Data Available
Stability conditions

No Data Available
Storage

No Data Available
Chemical s specifications

Gene target

tert-Butyloxycarbonyl 3-Fluoro-4-aminopiperidine
Gene symbol

MIR1302-4, PIRC18, PIRC16, SNORD114-4, IGKV2OR2-4, MIR941-4, PIRC19, PIRC17
Short name

1-(tert-Butyloxycarbonyl)-3-Fluoro-4-aminopiperidine
Alternative name

1-(telomerase reverse transcriptase-Butyloxycarbonyl)-3-Fluoro-4-aminopiperidine
Alternative to gene target

telomerase reverse transcriptase, CMM9 and DKCA2 and DKCB4 and EST2 and hEST2 and hTRT and PFBMFT1 and TCS1 and TP2 and TRT, TERT and IDBG-10998 and ENSG00000164362 and 7015, telomeric RNA binding, nuclei, Tert and IDBG-165912 and ENSMUSG00000021611 and 21752, BT.60929 and IDBG-632169 and ENSBTAG00000012567 and 518884

Identity

HGNC:5809
Gene

IGKV2OR2-4
Long gene name

immunoglobulin kappa variable 2/OR2-4 (pseudogene)
Synonyms gene name
- immunoglobulin kappa variable 2/OR2-4
- immunoglobulin kappa variable 2/OR2-4 pseudogene
Synonyms
- IGKV2/OR2-4
GenBank acession
- X51883
Locus

2q11.2
Discovery year

2000-04-18
Entrez gene record

28858
Pubmed identfication
- 2111145
Classification
- Immunoglobulin kappa (IGK) orphons

Name

Cloning, Molecular
Concept

Scope note: The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells.
Tree numbers
- E05.393.220
Qualifiers

drug effects, methods, radiation effects